Krystal Biotech (NASDAQ:KRYS) director Dino Rossi sells $8.2m shares — See source for full details.
$KRYS
Price history, market instrument context, member research, and related headlines in one place.
KRYS key statistics
Krystal Biotech, Inc. (KRYS) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $330.00, down $0.69 (0.21%) from the previous close of $330.69. It has traded between $328.51 and $338.91 in the latest session. Over the past year it has ranged from $183.03 to $382.54, leaving it in the upper half of its 52-week range (74%). Reported volume for the session was 283.9K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Related news
Krystal Biotech stock falls 7% on revenue miss despite earnings beat — See source for full details.
Krystal Biotech GAAP EPS of $1.79 beats by $0.16, revenue of $119.22M misses by $1.82M — See source for full details.